®®REDWOOD CITY, California - April 2, 2019 - Cadex Genomics, Corp. announced that it has been selected as a finalist in the Diagnostics category for the Pitch Perfect Startup Contest at the MedCity INVEST Event in Chicago, IL.
The MedCity INVEST Event brings together active investors with corporate business development executives to facilitate investment opportunities with the most promising startups in the healthcare diagnostics market segment.
Greg Schafer, Chief Commercial Officer of Cadex Genomics, will present at 11:30am Central Time on Wednesday April 24, 2019 in the Grand Ballroom at The Ritz Carlton Hotel, 160 East Pearson Street at Water Tower Place, Chicago, IL.
To schedule a meeting with Greg Schafer at the MedCity INVEST Event, contact Greg Schafer: gschafer@cadexgenomics.com or 650.292.2819.
About Cadex Genomics
Cadex Genomics™ is a privately-held molecular diagnostic assay company based in Redwood City, California that is improving cancer patient outcomes by providing physicians with better diagnostic tools to guide treatment.
For more information, please visit our website https://cadexgenomics.com. Alibrex and Cadex Genomics are trademarks of Cadex Genomics, Corp.